(Q41134675)

27 September 2017

1 reference

title

Metformin: an antihyperglycemic agent for treatment of type II diabetes (English)

1 reference

27 September 2017

0 references

1 reference

W R Melchior

1

1 reference

27 September 2017

L A Jaber

series ordinal

2

1 reference

27 September 2017

language of work or name

English

0 references

publication date

1 February 1996

1 reference

Annals of Pharmacotherapy

27 September 2017

published in

1 reference

27 September 2017

volume

30

1 reference

27 September 2017

issue

2

1 reference

27 September 2017

page(s)

158-164

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000210

27 September 2017

1 reference

Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000210

Antihyperglycaemic efficacy, response prediction and dose-response relations of treatment with metformin and sulphonylurea, alone and in primary combination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000210

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000210

Mechanism of Action of Metformin: Insulin Receptor and Postreceptor Effects in Vitro and in Vivo*

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000210

Cellular mechanism of action of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000210

Improvement with metformin in insulin internalization and processing in monocytes from NIDDM patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000210

Effect of metformin treatment on insulin action in diabetic rats: in vivo and in vitro correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000210

Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000210

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000210

Comparison of combined therapies in treatment of secondary failure to glyburide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000210

Sulphonylurea failure in type 2 diabetes: treatment with a basal insulin supplement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000210

Disposition of metformin (N,N-dimethylbiguanide) in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000210

Metformin kinetics in healthy subjects and in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000210

Reduction of metformin renal tubular secretion by cimetidine in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000210

Inferences and implications. Do results from the Diabetes Control and Complications Trial apply in NIDDM?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000210

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000210

Atherosclerosis in diabetes: the role of hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000210

Insulinemia and blood pressure. Relationships in patients with primary and secondary hypertension, and with or without glucose metabolism impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000210

Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000210

Insulin plus a Sulfonylurea Agent for Treating Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000210

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000210

Metformin reduces post-prandial insulin needs in type I (insulin-dependent) diabetic patients: Assessment by the artificial pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000210

10.1177/106002809603000210

21 January 2018

Identifiers

DOI

1 reference

27 September 2017

1 reference